News | Treatment Planning | August 23, 2019

Heidelberg University Hospital Treats First Patient Using Carbon Ion Therapy With RayStation

German hospital plans to use RayStation for all proton and carbon ion therapy treatment planning, including helium ion therapy beginning in 2020

Heidelberg University Hospital Treats First Patient Using Carbon Ion Therapy With RayStation

August 23, 2019 — Heidelberg University Hospital, Germany, has started using the RayStation treatment planning system for carbon ion therapy treatments. The center is now using RayStation for both particle therapy and photon therapy.

In April 2018, RayStation was selected as the treatment planning system for Heidelberg Ion Beam Therapy Center (HIT), which is the leading German facility for proton and carbon ion therapy and part of the Heidelberg University Hospital. An additional RayStation order for photon therapy was placed later that year, and RaySearch and Heidelberg University Hospital also entered into a long-term collaborative agreement regarding the clinical introduction of the RayCare oncology information system.

HIT has long expertise in advanced radiation therapy techniques and has been performing proton therapy and carbon ion therapy for the past 10 years. The center is now replacing its existing treatment planning system for protons and carbon ions and aims to use RayStation exclusively. Heidelberg University Hospital also treats patients using TomoTherapy, which is the focus of another cooperation between HIT and RaySearch. In addition, the center aims to begin treating patients using helium ion therapy by 2020. RayStation enables treatment planning for all of these modalities with a single software platform.

The HIT facility is an in-house medical product integrating a particle accelerator, a rotating ion gantry and an Iontris delivery system from Siemens Healthcare. The setup includes three treatment rooms, two horizontal treatment rooms,  and one gantry for both carbon ion and proton therapy. The gantry is the world’s first for carbon ion therapy. The facility has the capacity to treat up to 1,000 patients per year using particle therapy.

Jürgen Debus, professor and chairman, radiation oncology at Heidelberg University Hospital, said, “Carbon ion treatment planning in RayStation offers us unique options to optimize our treatment plans along with proton and photon precision radiotherapy.”

For more information: www.raysearchlabs.com

Related Content

Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...
Researchers reviewed results of prostate biopsies on over 3,400 men who had targets identified on prostate MRI and found that the positive predictive value of the test for prostate cancer was highly variable at different sites
News | Prostate Cancer | July 01, 2020
July 1, 2020 — Prostate MRI is an emerging technology used to identify and guide treatment for...
Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

News | Pediatric Imaging | June 29, 2020
June 29, 2020 — A type of smart magnetic r...
Case abstraction study period was from 10 March to 7 April 2020. Follow-up of abstracted cases was until 7 May 2020.

Case abstraction study period was from 10 March to 7 April 2020. Follow-up of abstracted cases was until 7 May 2020. Courtesy of Nature Medicine

News | Coronavirus (COVID-19) | June 25, 2020
June 25, 2020 — The characterization of COVID-19
Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration

Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration

News | Coronavirus (COVID-19) | June 23, 2020
June 23, 2020 — On June 23, 2020, ...
The Global Contrast Injectors Market will grow by $613.47M during 2020-2024, according to Technavio
News | Contrast Media Injectors | June 17, 2020
June 17, 2020 — Technavio has been monitoring the ...